| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,418 |
6,622 |
$765K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,708 |
5,340 |
$415K |
| 99199 |
Unlisted special service, procedure or report |
67,289 |
40,747 |
$379K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,141 |
1,774 |
$188K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,029 |
1,771 |
$188K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,670 |
2,261 |
$149K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,946 |
5,694 |
$124K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,107 |
958 |
$96K |
| 99401 |
|
3,282 |
2,655 |
$95K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
976 |
766 |
$90K |
| 97802 |
|
5,346 |
4,429 |
$72K |
| 99058 |
|
3,927 |
3,271 |
$61K |
| D0145 |
Oral evaluation for a patient under three years of age |
1,250 |
1,069 |
$39K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
720 |
578 |
$28K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,402 |
2,911 |
$26K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
516 |
412 |
$17K |
| D1206 |
Topical application of fluoride varnish |
1,270 |
1,088 |
$17K |
| 96127 |
|
3,600 |
2,887 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
829 |
660 |
$10K |
| 36410 |
|
638 |
539 |
$8K |
| 0001A |
|
186 |
137 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
568 |
478 |
$7K |
| 0002A |
|
209 |
128 |
$7K |
| 0072A |
|
111 |
71 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
41 |
24 |
$4K |
| 99383 |
|
33 |
27 |
$3K |
| 0071A |
|
82 |
50 |
$3K |
| 99215 |
Prolong outpt/office vis |
22 |
19 |
$2K |
| 0073A |
|
39 |
33 |
$2K |
| 0003A |
|
39 |
27 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
154 |
122 |
$1K |
| 0081A |
|
19 |
16 |
$1K |
| 99173 |
|
1,947 |
1,565 |
$947.92 |
| 36415 |
Collection of venous blood by venipuncture |
334 |
298 |
$873.83 |
| 85018 |
|
296 |
250 |
$505.16 |
| 85014 |
|
295 |
249 |
$505.16 |
| 96161 |
|
420 |
340 |
$489.30 |
| 83718 |
|
63 |
47 |
$474.70 |
| 83655 |
|
27 |
17 |
$253.81 |
| 82465 |
|
61 |
45 |
$241.20 |
| 92551 |
|
843 |
702 |
$220.50 |
| 36406 |
|
12 |
12 |
$129.00 |
| 81003 |
|
13 |
12 |
$30.47 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
146 |
121 |
$6.55 |
| 90716 |
|
131 |
125 |
$0.00 |
| 90686 |
|
3,044 |
2,569 |
$0.00 |
| 90651 |
|
264 |
215 |
$0.00 |
| 90688 |
|
28 |
27 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
310 |
265 |
$0.00 |
| 90620 |
|
271 |
223 |
$0.00 |
| 91305 |
|
64 |
48 |
$0.00 |
| 90680 |
|
82 |
75 |
$0.00 |
| 91307 |
|
518 |
312 |
$0.00 |
| 90696 |
|
14 |
14 |
$0.00 |
| 90619 |
|
52 |
44 |
$0.00 |
| 90674 |
|
171 |
106 |
$0.00 |
| 90656 |
|
132 |
123 |
$0.00 |
| 91300 |
|
211 |
109 |
$0.00 |
| 90633 |
|
255 |
218 |
$0.00 |
| 90670 |
|
468 |
409 |
$0.00 |
| 90707 |
|
76 |
74 |
$0.00 |
| 90685 |
|
104 |
96 |
$0.00 |
| 90648 |
|
26 |
26 |
$0.00 |
| 90756 |
|
47 |
46 |
$0.00 |
| 90734 |
|
55 |
41 |
$0.00 |
| 91308 |
|
52 |
43 |
$0.00 |
| 90715 |
|
36 |
24 |
$0.00 |
| 90655 |
|
15 |
14 |
$0.00 |